Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Hoon

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|September 12, 2006
Maturational changes in the in vivo activity of CYP3A4 in the first months of lifeK Allegaert, J N Van den Anker, A Debeer, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2006
Contribution of glucuronidation to tramadol disposition in early neonatal lifeKarel Allegaert, M Rayyan, J de Hoon, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2014
Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonatesR F W De Cock, A Smits, K Allegaert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 22, 2010
Voriconazole plasma levels in children are highly variableI Spriet, K Cosaert, M Renard, et al.
British Journal of Anaesthesia|June 14, 2005
Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activityK Allegaert, B J Anderson, R Verbesselt, et al.
Biochimica Et Biophysica Acta|January 28, 2012
Taxane resistance in breast cancer: a closed HER2 circuit?Joep P J de Hoon, Jürgen Veeck, Birgit E P J Vriens, et al.
Cancer Treatment Reviews|June 5, 2012
If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an exampleBirgit E P J Vriens, Dorien J A Lobbezoo, Joep P J de Hoon, et al.
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Neurogastroenterology and Motility|August 8, 2017
Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humansE Deloose, I Depoortere, J de Hoon, et al.
Epigenetics|March 5, 2011
Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylationAnette ten Haaf, Laura Franken, Caroline Heymann, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology and Therapeutics|September 12, 2006
Maturational changes in the in vivo activity of CYP3A4 in the first months of lifeK Allegaert, J N Van den Anker, A Debeer, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2006
Contribution of glucuronidation to tramadol disposition in early neonatal lifeKarel Allegaert, M Rayyan, J de Hoon, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2014
Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonatesR F W De Cock, A Smits, K Allegaert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 22, 2010
Voriconazole plasma levels in children are highly variableI Spriet, K Cosaert, M Renard, et al.
British Journal of Anaesthesia|June 14, 2005
Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activityK Allegaert, B J Anderson, R Verbesselt, et al.
Biochimica Et Biophysica Acta|January 28, 2012
Taxane resistance in breast cancer: a closed HER2 circuit?Joep P J de Hoon, Jürgen Veeck, Birgit E P J Vriens, et al.
Cancer Treatment Reviews|June 5, 2012
If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an exampleBirgit E P J Vriens, Dorien J A Lobbezoo, Joep P J de Hoon, et al.
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Neurogastroenterology and Motility|August 8, 2017
Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humansE Deloose, I Depoortere, J de Hoon, et al.
Epigenetics|March 5, 2011
Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylationAnette ten Haaf, Laura Franken, Caroline Heymann, et al.
Pageof 4